chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got coronavirus after having the Covid-19 vaccine shots; got coronavirus after having the Covid-19 vaccine shots; This is a spontaneous report from a Pfizer-sponsored program. This spontaneous report from a contactable consumer reporting same events under the same suspect product for 10 patients. This is one of 10 reports. A patient of unspecified age and gender received BNT162B2 (Pfizer BioNTech Covid 19 vaccine), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization.  The medical history and concomitant medications were not reported. The reporter had talked to 10 people that got coronavirus after having the Covid-19 vaccine shots.  The reporter stated that she doesn't believe in this stuff and doesn't trust it.  The reporter did not provide details for any of the patients that got coronavirus after having the Covid-19 vaccine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : PFIZER INC-2021527957 same drug/AE, different patient
minimal pain at the injection site; This is a spontaneous report from a Pfizer-sponsored Program. A non-contactable physician (patient) reported that a 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included many allergies including allergy to shellfish. The patient's concomitant medication included diphenhydramine hydrochloride (BENADRYL). The patient got COVID vaccine and before she took the vaccine she had Benadryl as she has many allergies including allergy to shellfish. She experienced minimal pain at the injection site on an unknown date. Reporter wanted to know if Benadryl affect the efficacy of the vaccine and if Benadryl would decrease the efficacy of COVID vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever 101, chills, nausea, vomiting, dizziness first 24 hours.  After 24 hours, ongoing severe nausea and dizziness.  Missed four days of work so far and was told symptoms may last up to 8 weeks by doctor.
This spontaneous report was received from a registered nurse and referred to an unspecified number of patients of unknown age and sex. On an unknown date, the unspecified number of patients may have received improperly stored PEDVAXHIB (lot #, expiration date, strength, dose and frequency were not reported). No adverse effects were reported. This is one of four reports received from the same source. Additional information has been requested.
Chills, fever, shivering, nausea, prevented sleep, muscle aches, headache -- lasted most of the night. Around 8 am the next morning most symptoms had subsided.
This spontaneous report as received from a pharmacy technician refers to two patients of unknown age and gender. On an unknown date in 2014 (reported as sometimes in the last two months) the patients were vaccinated with PNEUMOVAX23 (dose, strength not reported) (lot # K004148, exp date: 10-MAY-2014). The reporter stated that on an unknown date in 2014 the patients experienced extreme injection site reactions including swelling and redness. The outcome of events was unknown. The relatedness between events and PNEUMOVAX23 was not reported. No Product Quality Complaint (PQC) reported. The reporter stated that at least three patient's (two described in this report and one described in report #1409YSA013405) returned to the pharmacy with complaint about having bad reactions after vaccination with PNEUMOVAX23 with this lot #. The reporter requested lot check and would like to return the remaining vaccines with this lot and get replacements depending on the results of the lot check. This is one of several reports from the same reporter (other MARRS # 1409USA013405). Additional information has been requested.
Pt. states that he didn't feel well overall and that there was massive swelling in his legs & feet after being vaccinated with high-dose FLUZONE.
Swollen face, eyes lids, nose and lips. Received the vaccine on 1-11-21. Experienced left arm numbness and pain on site. Numbness subsided and pain was minimal. Went to bed and work up around 6am to face, eyes, nose and lips swollen. Barely unable to open eyes. Immediately contacted  employer employee health and contacted PCP. Appointment scheduled with PCP. PCP assessment completed. Recommended prednisone for swelling. Unable to take because of previous reaction. Recommended for Benadryl to be taken every 4-6 hrs and also Ibuprophen
Allergic reaction; Allergic reaction that developed into a bacterial infection of the lower leg (Cellulitis); itching; Heavy fatigue; vomiting; diarrhea; headache; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 03May2021 at 08:45 AM (Batch/Lot Number: EW0173) at the age of 40-years-old as 2nd dose, single for COVID-19 immunization at a pharmacy or drug store. The patient had no other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient's medical history included complex regional pain syndrome (CRPS) from an unknown date and unknown if ongoing. The patient had no known allergies. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and lamotrigine (LAMICTAL); both taken for unspecified indications, start and stop dates were not reported (received within 2 weeks of vaccination). The patient previously received the first dose of BNT162B2 (Lot number: ER8729) on 15Apr2021 at 02:15 PM in the left arm for COVID-19 immunization. On 03May2021 at 11:00 AM, the patient experienced allergic reaction that developed into a bacterial infection of the lower leg (Cellulitis). There was extreme pain and burning in addition to itching, and the patient also experienced heavy fatigue, vomiting, diarrhea, and headache. The events resulted in doctor or other healthcare professional office/clinic visit and also emergency room/department or urgent care. The patient was treated with antibiotics for the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.
This is one of four patients who devel fever, redness & tenderness @ the inj site;no further details known @ present;
pt was given PCV23 today thinking it was 1st ever.  Both provider and assistant had checked chart and Alert and no PCV23 seen. After shot given found in chart PCV23 was given 8/2011
Chills; Fever; Sore Arm; Arthralgia; Myalgia; This is a spontaneous report from a non-contactable consumer, the patient. An adult non-pregnant female patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Aug2021 as a single dose for COVID-19 immunisation. Medical history included COVID-19, diagnosed prior to the vaccination. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 03Aug2021, the patient experienced chills, fever, sore arm, arthralgia and myalgia. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, sore arm, arthralgia and myalgia was resolved with sequelae on an unknown date in Aug2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given .25ml of influenza vaccine with preservative at 2 months of age. No adverse reactions noted. Patient's mom notified. Dr, Pharmacy and poison control notified.
This spontaneous report was received from a healthcare worker reporting on an unknown number of patients of an unkonwn age and gender, that since 13-JAN-2015, had been vaccinated with a dose of ZOSTAVAX (dose, dose number, lot number, expiration date and route were not reported), which underwent supported temperature excursions. No adverse effects reported. Co-suspect and concomitant therapies were not reported. Additional information has been requested. This is one (1) of two (2) reports from the same source.
This spontaneous case reported by a consumer, describes the occurrence of dizziness (dizzy/lightheaded) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced dizziness (dizzy/lightheaded). The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Patient was monitored for about an hour after the vaccine injection. She complained of chest tightness and had increase in blood pressure and heart rate.
Irregular Heart Rate fluctuations ranging from as low as 50 to as high as 100 BPM; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE ABNORMAL (Irregular Heart Rate fluctuations ranging from as low as 50 to as high as 100 BPM) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Penicillin , gabapentin).    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced HEART RATE ABNORMAL (Irregular Heart Rate fluctuations ranging from as low as 50 to as high as 100 BPM). At the time of the report, HEART RATE ABNORMAL (Irregular Heart Rate fluctuations ranging from as low as 50 to as high as 100 BPM) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Aug-2021, Heart rate: abnormal (abnormal) Abnormal (Irregular Heart Rate fluctuations ranging from as low as 50 to as high as 100 BPM).     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication was reported.   No treatment history was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Aug-2021: Follow-up received on 24 Aug 2021 included no new information.
Pt received GARDASIL #3 - HepA #1 FLUMIST. At about 10 m. after immunization, pt developed a syncopal episode became unresponsive for about 2 m. placed on supine position skin warm & dry. BP 113/66 Pulse 82. Resp non labored. Pulse Ox 98% BS 90 mg/dl. after stimulation became responsive about 3:50 PM.
The patient presented with moderate vasovagal reaction post-vaccine. The patient was given aggressive oral hydration. After this and with close monitoring, she returned to baseline. She was returned home with her husband as the driver.
Patient came to clinic 3 days later reporting upper arm turned red and sore down to elbow including underside of arm.  Underside of arm was still red at this time but the rest of the arm had cleared.  Reported to nurse and provider but patient was not seen by a provider for this.
This spontaneous report as received from a nurse refers to a 19 year old patient of unknown gender. On an unknown date (reported as a couple of weeks ago), the patient was inadvertently received one pediatric dose of VAQTA 25/0.5 (unit not reported) (dose, lot #, expiration date and route not reported) instead of one adult dose of VAQTA for prophylaxis. No adverse effects were reported.
Received this Johnson&Johnson dose after previously receiving one dose of the Moderna vaccine on 6/20/2021
Pain at the injection site; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced pain at the injection site after administering the vaccine on an unspecified date. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
bottom of legs and both forearms itching; Rash; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 intramuscular, administered in the left arm (upper) on 03Mar2021 at 15:45 (Batch/Lot Number: EN6199) as dose 1, single (at the age of 67-years-old) for Covid-19 immunisation. The patient's medical history and concomitant medications were reported as 'no'. No history of previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available and no additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations (within 4 weeks) and no adverse events (AEs) following prior vaccinations. No relevant test done. She got the Covid 19 vaccine last Wednesday. She did not think she had any reaction. On Friday night, 05Mar2021, about 48 hours later, the bottom of her legs and both forearms started itching. Then on Sunday, she noticed a rash, it's not bad, she knows it is there, if she looks at it up closely. Stated she has elderly skin that is sun damaged, wrinkled, and dry. Stated the rash may have worsened. She knew she was itching and could not tell there was a rash there, states she may have had the rash as of Friday, but she could not see it or feel it. The rash is located on her lower legs below the knee down to the ankles on both legs. She took Benadryl the day prior and an anti-itch over the counter cream like Benadryl, when she puts on the cream it stops it a good bit. She was asking if she should get the second injection. The events had not resolved at the time of the report.   No follow up attempts are possible. No further information is expected.
not been feeling well; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not been feeling well) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (not been feeling well). At the time of the report, MALAISE (not been feeling well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Small urticarial rash on forehead and back of neck. No angioedema, airway compromise or rash anywhere else. Recommended topical BENADRYL to help decrease itching. Reviewed signs of respiratory distress or anaphylaxis like sx and when to go to ER.
pt recv vax 4DEC96 & 12DEC96 pt devel a very mild case of chicken pox;21DEC96 pt recovered from this exp;
A dose of GARDASIL 9 was administered to a patient that is 8 weeks and 5 days pregnant; No additional AE reported; This spontaneous prospective pregnancy report was received from a medical assistant, regarding a 34-year-old female patient. The patient's drug reactions or allergies included sulfa allergies; her concomitant medications included doxylamine succinate (+) pyridoxine hydrochloride (BONJESTA) and prenatal vitamins. It was not reported information regarding the patient's medical history or her concurrent conditions. The patient became pregnant with last menstrual period (LMP) calculated as 08-AUG-2021 (and estimated date of delivery (EDD) of 15-MAY-2022), based on a pregnancy gestation reported as 8 weeks and 5 days, at the time of the report.  On 08-OCT-2021, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 milliliters (mL) administered intramuscularly (lot number U007652 has been verified to be a valid lot number, expiration date reported and established as 14-APR-2023) (vaccination scheme frequency, anatomical location of administration were not reported) as routine vaccination (prophylaxis) (exposure during pregnancy). At the time of the report, the pregnancy outcome was pending, the fetal outcome was not provided, and the patient did not experience any additional adverse events (no adverse event).
Flu Like symptoms   achy, sweating, headache, redness and swelling at injection site.
Nausea, vomiting, chills, slight spike in body temperature 99.4, extreme migraine, left arm pain/numbness, slight dry cough, extreme fatigue, and muscle aches. Symptoms lasted 3 days and started 6 days after getting the vaccine. Subsided after rest and asprin.
Fever; Chills; Fever; Chills; Stomach cramps; Stabbing pain in gut; Loss of appetite; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps), GASTROINTESTINAL PAIN (Stabbing pain in gut), DECREASED APPETITE (Loss of appetite), the first episode of PYREXIA (Fever) and the first episode of CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No other medical history reported.  Concurrent medical conditions included Food allergy (Unspecified), Drug allergy (Codeine) and Allergy to chemicals NOS (Highly allergic to chemicals - Felt tip pen).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps), GASTROINTESTINAL PAIN (Stabbing pain in gut), DECREASED APPETITE (Loss of appetite) and the first episode of CHILLS (Chills). On 13-Feb-2021, the patient experienced the first episode of PYREXIA (Fever). On 24-Feb-2021, the patient experienced the second episode of PYREXIA (Fever) and the second episode of CHILLS (Chills). On 17-Feb-2021, ABDOMINAL PAIN UPPER (Stomach cramps), GASTROINTESTINAL PAIN (Stabbing pain in gut) and DECREASED APPETITE (Loss of appetite) had resolved. At the time of the report, last episode of PYREXIA (Fever) and the last episode of CHILLS (Chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Bismuth subsalicylate (PEPTOBISMOL) was noted as a concomitant medication but was also listed as a treatment medication.  The patient consulted her healthcare provider who recommended acetaminophen (TYLENOL) and water but no acetaminophen (TYLENOL) was consumed. The patient reported that her fever and chills recurred a week after her initial report, but have since resolved on an unknown date. The patient only received one dose of the vaccine because she was advised not to get the second dose. She was contemplating whether to get another vaccine for the second dose.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: New events of fever and chills added. Chemical allergy updated in medical history.
After vaccination was administered, he customer walked to the cooler to exchanged a beverage. At checkout he passed out and EMS was summoned.
arm at injection site has been red and not healed in the almost 2 years since I got shot
Started on 10/11/13 with a sore arm on 10/12/13 am developed redness and swelling and heat at site. Progressed on 10/13/13 swelling started dropping down arm.
Rectal bleeding; This serious case was reported by a consumer via call center representative and described the occurrence of rectal bleeding in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 01-MAR-2023, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rectal bleeding (Verbatim: Rectal bleeding) (serious criteria GSK medically significant). The outcome of the rectal bleeding was not resolved.   It was unknown if the reporter considered the rectal bleeding to be related to Shingrix.     It was unknown if the company considered the rectal bleeding to be related to Shingrix.   Additional Information: GSK Receipt Date: 18-APR-2023. The consumer reported that he had a Shingrix vaccination administered at the first of March 2023.  The consumer reported that he was now having rectal bleeding.   No further information was known. The reporter did not consent to follow up. The consumer declined to provide consent, Doctor of medicine name, phone number, as well, his date of birth and address.   The reporter stated that he did not want his information out there.
Pt recvd 3 doses of Engerix-B 18DEC90, 7FEB91, 31JUL91 & it was determined that pt did not respond; Engerix-B doses 4 & 5 were administered 24SEP91 & 7NOV91;
Patient presented to office with redness, hot to touch, knot at injection site, and treated with VERIPRED 20mg.
Patient felt itchiness after the vaccine.  She did not mention to us on the day of vaccination (April 1st), but came on April 5th since the itchiness was worse. She was planning on going to urgent care to check it out.
After first dose I ran to the bathroom to splash water on my face, I felt extremely hot and was sweating out of no where.. I was worried I was going to faint. So I laid down on the bathroom floor and put my feet up in hopes to get the blood back to my head. After a few minutes I left and went back to work (surrounded by doctors) Throughout the day I continued to feel extremely light headed and faint like. As I was driving home around 5PM I got a numbing tingling feeling on my face I've never experienced before. To the point of needing to pull my car over, I felt it was unsafe to drive. After I gathered myself I had to roll all the windows down to freeze my self in order to feel safe enough to get to my Son's Daycare provider.  Days went on and I would get this numbing/tingling feeling in my face over and over throughout the day. My BP was all over the place dropping and rising a lot. I would get so sick to my stomach I would have to take nausea medication. About a month later it started to fade. Now I feel almost like I had a stroke, my brain doesn't seem to work like it use to. I feel like I am in a fog.
pt vax 23jul97 & 8jul98, respectively. approx 2wks p/ 2nd vax pt devel a varicella-like rash w/approx 20 itchy lesions